Thromb Haemost 1977; 37(02): 274-282
DOI: 10.1055/s-0038-1649228
Original Article
Schattauer GmbH

Prevention of Platelet Adhesion and Aggregation by a Glutardialdehyde-Stabilized Heparin Surface

P Olsson
*   Surgical Research Laboratory, Thoracic Clinics, Karolinska Sjukhuset, Stockholm, Sweden
,
H Lagergren
*   Surgical Research Laboratory, Thoracic Clinics, Karolinska Sjukhuset, Stockholm, Sweden
,
R Larsson
**   Aminkemi AB, Stockholm, Sweden
,
K Rådegran
*   Surgical Research Laboratory, Thoracic Clinics, Karolinska Sjukhuset, Stockholm, Sweden
› Author Affiliations
Further Information

Publication History

Received 18 May 1976

Accepted 30 September 1976

Publication Date:
03 July 2018 (online)

Summary

A stable heparinized surface was prepared by sequential treatment of polyethylene with water solutions of hexadecylamine hydrochloride, heparin and glutardialdehyde. In order to explain the “non-thrombogenic” properties of this surface, it was evaluated with regard to prevention of platelet adhesion and aggregation.

Human heparinized blood (2 and 10 IU/ml) with 51Cr-labelled autologous platelets was rotated for 60 minutes in untreated and heparin-treated circular tubings. The surface area/blood volume ratio was varied and an air-blood interface was present. In untreated tubings, platelet adhesion and aggregation increased in proportion to the size of the surface area/blood volume ratio, irrespective of the heparin concentrations of the blood. In the heparin-treated tubings, there was no measurable platelet adhesion to the surface and no platelet aggregation in the blood. The difference between the heparinized and the untreated surfaces with regard to platelet adhesion was discernible even after 10 minutes storage of stagnant blood.

It is concluded that platelet adhesion and aggregation induced by exposure of blood to a foreign surface in an in vitro experimental model can be prevented by a stable heparin coating of the surface.

 
  • References

  • 1 Aas K. A, Gardner F. H. Survival of blood platelets labelled with chromium1 . Journal of Clinical Investigation 1958; 37: 1257
  • 2 Abrahamsen A. F. A modification of the technique for Cr51 labelling of blood platelets giving increased circulating platelet radioactivity. Scandinavian Journal of Haemotology 1968; 5: 53
  • 3 Andersson L. O, Borg H, Miller-Anders son M. Purification and characterization of human factor IX. Thrombosis Research 1975; 7: 451
  • 4 Baier K. E, Dutton R. C. Initial events in interactions of blood with a foreign surface. Journal of Biomedical Material Research 1969; 3: 191
  • 5 Bruck S. D, Rabin S, Ferguson R. J. Evaluation of biocompatible materials. Biomaterials, Medical Devices, and Artificial Organs 1973; 1: 191
  • 6 Chandler A. A. In vitro thrombotic coagulation of the blood. A method for producing a thrombus. Laboratory Investigation 1958; 7: 110
  • 7 Danishefsky I, Tzeng F. Preparation of heparinlinked agarose and its interaction with plasma. Thrombosis Research 1974; 4: 237
  • 8 Eldh P, Jacobsson B. Heparinized vascular catheters: A clinical trial. Radiology 1974; 111: 289
  • 9 Gentry P. W, Alexander B. Specific coagulation factor adsorption to insoluble heparin. Biochemical and Biophysical Research Communication 1973; 50: 500
  • 10 Hershgold E. J, Kwan-Gett C. S, Kawai J, Rowley K. Haemostatis, coagulation and the total artificial heart. Transactions of the American Society for Artificial Internal Organs 1972; 18: 181
  • 11 Hill J. D, deleval M. R, Mielke C. H, Bramson M. L, Gerbode F. Clinical prolonged extracorporeal circulation for respiratory insufficiency. Transactions of the American Society for Artificial Internal Organs 1972; 18: 546
  • 12 Jacobsson B, Schlossman D. Thrombogenicity of heparinized vascular catheters. Acta Radiologica Diagnosis (Stockholm) 1973; 14: 569
  • 13 Kim S. W, Lee R. G, Oster H, Coleman D, Andrade J. D, Lentz D. J, Olsen D. Platelet adhesion to polymer surfaces. Transactions of the American Society for Artificial Internal Organs 1974; 20: 449
  • 14 Kristensson A. A new method for the direct counting of the so-called blood platelets in man. Acta Medica Scandinavica 1922; 57: 301
  • 15 Lagergren H. R, Eriksson J. C. Plastics with a stable surface monolayer of cross-linked heparin: Preparation and evaluation. Transactions of the American Society for Artificial Internal Organs 1971; 17: 10
  • 16 Lagergren H. R, Olsson P, Swedenborg J. Inhibited platelet adhesion. A nonthrom-bogenic characteristic of a heparin coated surface. Surgery 1974; 75: 643
  • 17 Larsson R. L, Hielte M.-B, Eriksson J. C, Lagergren H. R, Olsson P. The stability of glutardialdehyde-stabilized 35S-heparinized surfaces in contact with blood. Thrombosis and Haemos-tasis 1976; 37: 262
  • 18 Lindsay R. M, Prentico C. R. M, Davidson J. F, Burton J. A, McNicol G. Haemostatic changes during dialysis with thrombus formation on dialysis membranes. British Medical Journal 1972; 4: 454
  • 19 Mason R. G. The interaction of blood haemostatic elements with artificial surfaces. Progress of Haemostasis and Thrombosis 1972; 1: 141
  • 20 Miller-Andersson M, Borg H, Andersson L. O. Purification of antithrombin III by affinity chromatography. Thrombosis Research 1974; 5: 439
  • 21 Nossel H. L. The contact phase of blood coagulation. Blackwell Scientific Publications; Oxford.: 1964
  • 22 Rodman N. F, Mason R. G. Blood-foreign surface interaction. Thrombosis et Diathesis Haemorrhagica 1970; Suppl. 42: 61
  • 23 Salzman E. W. Blood platelets and extracorporeal circulation. Transfusion 1963; 3: 274
  • 24 Salzman E. W, Merril E. W, Binder A, Wolf C. F. W, Ashford T. P, Austen W. G. Protein-platelet interaction on heparinized surfaces. Journal of Biomedical Material Research 1969; 3: 69
  • 25 Salzman E. W. Role of platelets in the blood surface interactions. Federation Proceedings 1971; 30: 1503
  • 26 Scarborough D. E, Mason R. G, Dalldorf P. G, Brinkhous K. M. Morphological manifestations of blood - solid interfacial reactions - a scanning and transmission electron microscopic study. Laboratory Investigation 1969; 20: 164